Close
Home - Press releases - Acquisition of Argatroban business in Europe

Do you have
any question?

Contact us
17/06/2024

Acquisition of Argatroban business in Europe

#acquisition#argatroban#portfolio#strategy

Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra®, Arganova®, Novastan®, Exembol®), in Europe.

ACQUISITION OF ARGATROBAN BUSINESS IN EUROPE

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.